Predicting Alzheimer's Disease with Plasma Protein Biomarkers
Author Information
Author(s): Zhuang Tianchi, Xu Ting, Qiu Xichenhui, Yang Yingqi, Qi Xiang, Xu Qin, Ji Minghui
Primary Institution: Nanjing Medical University
Hypothesis
Can novel plasma protein biomarkers be used to predict the onset of Alzheimer's disease?
Conclusion
The study found that specific plasma protein signatures can effectively predict the risk of Alzheimer's disease onset.
Supporting Evidence
- Seven protein signatures were identified as predictive of Alzheimer's disease risk.
- The Cox model showed robust predictive performance with AUC values of 0.77 at 4, 6, and 8 years.
- Low-risk individuals had significantly delayed Alzheimer's onset compared to high-risk individuals.
Takeaway
Scientists found that certain proteins in the blood can help tell if someone might get Alzheimer's disease in the future.
Methodology
The study used Cox regression, LASSO regression, and cross-validation to analyze data from participants.
Limitations
Weak correlations were observed between plasma and CSF protein levels.
Participant Demographics
Participants were aged 60 and above from the Alzheimer’s Disease Neuroimaging Initiative cohort.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website